Understand why testing must evolve beyond deterministic checks to assess fairness, accountability, resilience and ...

Vyriad, a gene therapy company based in Rochester, has raised $85 million to support its new VV-169 cancer treatment which ...

In this week's "It's Debatable" segment, Rick Rosen and Charles Moster debate on the question: Should ethical/legal restrictions on human testing be lifted to expedite the development of new ...